Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PV-10 in metastatic melanoma
NCT00521053Phase 2Completed
- Sponsor
- Provectus Biopharmaceuticals
- Start
- Sep 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of PV-10 in melanoma, sponsored by Provectus Biopharmaceuticals. Started Sep 2007; status: completed.
02
Drugs
PV-10
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00521053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521053.